FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 and 17

Novavax announced on Saturday that its Covid-19 vaccine has been authorized for emergency use by the FDA for adolescents between the ages of 12 and 17.

from Health and Science https://ift.tt/zEfWCJe
https://ift.tt/EV3tM1c
https://ift.tt/vCjuBXS